🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Anyone else get super cold on tirz? I am FREEZING — 6 month update Page 2

Anyone else get super cold on tirz? I am FREEZING — 6 month update

GenomicsKate Wed, Jun 12, 2024 at 7:22 PM 17 replies 2,021 viewsPage 2 of 4
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jun 14, 2024 at 2:55 AM#6
Dr.CardioMD said:
SURMOUNT-1 landed around 20.9% mean weight loss at 15mg over 72 weeks, against roughly 15% for semaglutide 2.4mg in STEP 1.

Pushing back on Dr.CardioMD here. The "tirzepatide is simply better" summary irritates me. It is better on mean weight loss, and the cardiovascular outcome evidence is far thinner than semaglutide's. If the reason for treating is cardiovascular risk rather than weight, the evidence base points the other way.

Last edited: Jun 14, 2024 at 3:55 AM
29 24maya_sedona, stefan_berlin, Dr.EM_Chicago and 26 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Jun 14, 2024 at 3:31 PM#7

Adding the numbers, since they settle part of this. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

28 23Dr.GutHealth, amsterdam_pete, LondonLisa and 25 others
Reply Quote Save Share Report
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Jun 15, 2024 at 4:08 AM#8
BethLabQueen said:
The "tirzepatide is simply better" summary irritates me.

There is a second half to this that has not been said yet. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

27 22NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 24 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
RegAffairsDC
Member
678
3,456
May 2024
Washington, DC
Jun 15, 2024 at 4:45 PM#9

A narrower follow-up, since the general answer is now clear:

Whether anyone has held 10mg long term rather than climbing, and what happened over the following year?

26 21sean_dublin, hannah_MT, Dr.SportsMedIN and 23 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Jun 18, 2024 at 5:20 AM#10

OP back with an update, since a thread like this is useless without one.

Reporting back after another eight months at the same dose. Still losing slowly, no new side effects, and no reason I can find to climb further.

22 20claudia_zurich, nancy_portland, rick_sfbay and 19 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register